Pérez-Acuña F, Monsalve P, Pérez J, Pérez J, Tremarias A, Sanabria A, Fragachán F
Eur J Clin Pharmacol. 1983;25(2):151-5. doi: 10.1007/BF00543784.
Clonidine was administered by intravenous infusion to 12 patients classified as having exaggerated arterial hypertension, their systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures were significantly reduced from the third min. The maximal percentage reduction (Mean +/- SEM) reached 30.1 +/- 3.1% (SAP) and 24.7 +/- 2.9% (DAP) after 30 to 110 min of infusion. Initially there were transitory initial increases in SAP (3 patients) and DAP (1 patient). The increases in blood pressure were related to low body surface area (BSA). The dose of clonidine per m2BSA able to reduce by 10% either SAP or DAP (active dose-10), and the dose able to reduce SAP or DAP by 10 mmHg in one minute (systolic or diastolic clonidine unit) were calculated, providing indices for detecting clonidine responsiveness in patients with exaggerated hypertension. This method is advantageous when using clonidine intravenously because it diminishes the risk of overdosage.
对12名被归类为重度动脉高血压的患者进行了可乐定静脉输注,从第3分钟起,他们的收缩压(SAP)、舒张压(DAP)和平均动脉压(MAP)均显著降低。输注30至110分钟后,最大降低百分比(平均值±标准误)达到30.1±3.1%(SAP)和24.7±2.9%(DAP)。最初,有3名患者的SAP和1名患者的DAP出现短暂的初始升高。血压升高与低体表面积(BSA)有关。计算了每平方米体表面积能使SAP或DAP降低10%的可乐定剂量(活性剂量-10),以及能在一分钟内使SAP或DAP降低10 mmHg的剂量(收缩压或舒张压可乐定单位),为检测重度高血压患者对可乐定的反应性提供了指标。静脉使用可乐定时,这种方法具有优势,因为它降低了过量用药的风险。